The 6 Wall Street analysts offering CLOVER HEALTH INVESTMENTS CO stock forecast in the last 6 months have average price target of $3.5 with a high forecast of $6.0 and a low forecast of $2.5. The average CLOVER HEALTH INVESTMENTS CO stock forecast represents a 38.34% increase from the last price of $2.52999997138977.
Is Clov stock about to go higher?
But by the rumblings on the Reddit message boards, CLOV stock is about to go higher. Clover has been one of the “stonks” that are a part of the investing landscape in 2021. Affectionately called the “apes,” this network of traders is ready to place their diamond hands on the stock.
What is clover stock’s all-time high?
Earlier this summer, Clover’s stock briefly traded at $28.85, an all-time high. It was only the second time in its short history as a public company that it traded over $15.
What will be the price of Clov in 2022?
The predicted opening price is based on yesterday's movements between high, low, and the closing price. On Feb 02, 2022 "Cowen" gave "$7.00 - $3.00" rating for CLOV.
What are the resistance levels for Clover health investments stocks?
For Clover Health Investments stocks, the 50-day moving average is the resistance level today. For Clover Health Investments stocks, the 200-day moving average is the resistance level today. Are you interested in Clover Health Investments, Corp. stocks and want to buy them, or are they already in your portfolio?
Is CLOV expected to go up?
Clover Health Investments Corp (NASDAQ:CLOV) The 6 analysts offering 12-month price forecasts for Clover Health Investments Corp have a median target of 3.00, with a high estimate of 7.00 and a low estimate of 2.50. The median estimate represents a +42.18% increase from the last price of 2.11.
Is CLOV a good stock to buy?
By some measures Clover Health Investments (NASDAQ:CLOV) was a big deal Tuesday.
What is the target price for CLOV?
$3.00Stock Price Target CLOVHigh$7.00Median$3.00Low$2.50Average$3.67Current Price$2.51
Is Clover Health undervalued?
Clover Health Investments shows a prevailing Real Value of $3.14 per share. The current price of the firm is $2.24. Based on Macroaxis valuation methodology, the firm appears to be undervalued.
Is CLOV being shorted?
CLOV currently has 15% of its float shorted, according to data from Yahoo Finance, a number that could be high enough to put the stock on the edge of a short squeeze. There has been an increase of 5 million shares shorted, representing almost 20%, from July 29 to August 12.
Is CLOV a buy Zacks?
The Price to Earnings ratio or P/E is price divided by earnings....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy25.08%2Buy18.56%3Hold10.15%4Sell5.79%2 more rows
How much does it cost to buy Clov?
One share of CLOV stock can currently be purchased for approximately $2.51.
What is Nio price target?
Stock Price Forecast The 30 analysts offering 12-month price forecasts for NIO Inc have a median target of 30.01, with a high estimate of 81.75 and a low estimate of 21.77. The median estimate represents a +61.01% increase from the last price of 18.64.
Is Clover a public company?
On November 15th, Clover Health announced an upsized public offering of about 52.2 million shares at 5.75 per share. With projected gross proceeds of about $300 million, the company plans to spend fresh funds for working capital and general corporate purposes.
What is going on with clover health?
Clover Health posted a $48.4 million loss in the first quarter of 2021, nearly doubling its year-over-year losses as medical costs jumped under the pandemic. The startup insurer reported a $28.2 million loss in the first quarter of 2020, according to the company's earnings report released this week.
Is Clover Health Investments a buy right now?
8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last twelve months. The...
When is Clover Health Investments' next earnings date?
Clover Health Investments is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022. View our earnings forec...
How were Clover Health Investments' earnings last quarter?
Clover Health Investments, Corp. (NASDAQ:CLOV) released its quarterly earnings data on Monday, May, 9th. The company reported ($0.19) earnings per...
What guidance has Clover Health Investments issued on next quarter's earnings?
Clover Health Investments issued an update on its FY 2022 earnings guidance on Monday, May, 23rd. The company provided earnings per share (EPS) gui...
What price target have analysts set for CLOV?
8 equities research analysts have issued 1 year price targets for Clover Health Investments' stock. Their forecasts range from $2.50 to $10.00. On...
Who are Clover Health Investments' key executives?
Clover Health Investments' management team includes the following people: Mr. Vivek Garipalli , Co-Founder, CEO & Chairman of Directors (Age 44)...
Who are some of Clover Health Investments' key competitors?
Some companies that are related to Clover Health Investments include UnitedHealth Group (UNH) , Anthem (ANTM) , Cigna (CI) , Humana (HUM) , Ce...
What is Clover Health Investments' stock symbol?
Clover Health Investments trades on the NASDAQ under the ticker symbol "CLOV."
Who are Clover Health Investments' major shareholders?
Clover Health Investments' stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group...
Signals & Forecast
There are mixed signals in the stock today. The Clover Health Investments, Corp. stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal.
Support, Risk & Stop-loss
Clover Health Investments, Corp. finds support from accumulated volume at $2.45 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Is Clover Health Investments, Corp. stock A Buy?
Clover Health Investments, Corp. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Insiders are positive buying more shares than they are selling in Clover Health Investments, Corp
In the last 64 trades there were 231.32 million shares bought and 138.32 million shares sold. The last trade was done 27 days ago by Reynoso Jamie L. who bough 15.77 thousand shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside.
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
How many CLOV shares were shorted on June 7?
According to data from Fintel, over 39 million CLOV shares were sold short on June 7, which was almost 32 percent of the volumes on that day. In contrast, fewer than a million CLOV shares were sold short on May 26, while the short volume ratio was around 11.2 percent.
How much will Clover Health make in 2021?
In 2021, Clover Health expects to generate revenues between $810 million and $830 million , which would mean a 2021 EV-to-sales multiple of 5.5x at the midpoint. It's worth noting that the forecast for 2021 is below the $880 million that was provided at the time of the merger.
Only Cheap if You Assume Profitability Is Imminent
Yes, at the current CLOV stock price (around $4.47 per share), it’s obviously not as pricey as it was at $10, $15, $20 or even $28.85 per share. Trading for less than 1x projected sales for 2022, this “disruptor” now trades at a forward valuation more in-line with its old-school peers.
Bottom Line on Clover
I concede that it’s not impossible for Clover to one day become profitable. Assuming it continues to grow its revenues by high double-digits. The issue is with the timeline.
The Other Side of the Clover Story
Back here on planet Earth, Clover Health has some things to like. But it also has significant areas of concern. For starters, the company provides insurance in the low-margin Medicare market. Like all Medicare insurance providers, the company is paid a fixed amount by the federal government. This amount is based on a statutory formula.
Is CLOV Stock a Buy?
I feel almost certain that CLOV stock is going to move higher in the short term. How much higher and how long it will last are anybody’s guess.
CLOV : Clover Health Investments, stock forecast by Wall Street Analysts
The average Clover Health Investments, stock forecast from last 6 month is $8.33, and this show a 12.5% increase in average from the prior price target of the each prediction. Also, this average forecast of $8.33 represents a -30.58% decrease from the past average forecast of $12.0, 6 months ago from 6 wall street analysts.
Frequently Asked Questions about Clover Health Investments, stock forecast
From Clover Health Investments, stock forecast , Clover Health Investments, (CLOV) stock can be a good investment choice. According to AI Pickup, the Clover Health Investments, stock price forecast for 2022 Feb. is $3.2170031700703
Analysts Do Signal a Trend
Despite my skepticism regarding analysts, they do tend to foreshadow a stock’s future direction. As they pile in, investors take that as a sign that the company in question is worthy of investor interest. So they follow along.
The Bottom Line
InvestorPlace’s David Moadel recently pointed out that Clover is putting up respectable revenue through its Medicare Advantage customers and the Direct Contracting business. It’s on track to generate $1.6 billion in annual revenue.
Historical and forecast chart of Clover Health Investments stock
The chart below shows the historical price of Clover Health Investments stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast.
Clover Health Investments Daily Price Targets
Forecast target price for 02-23-2022: $ 2.30. Positive dynamics for Clover Health Investments shares will prevail with possible volatility of 11.547%.
Clover Health Investments forecast for this year
An uptrend is forecast for this month with an optimal target price of $ 2.56414. Pessimistic: $2.20. Optimistic: $2.86
Clover Health Investments information and performance
Clover Health Investments, Corp. is a provider of health insurance programs. The company offers hospital, medical and private insurance services. Clover Health Investments serves clients in the United States.
